Timothy Cramer, MD
Interventional Pain Medicine · Oklahoma City, OKNPI 1275947335
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Medtronic accounts for 61.8% of it on its own, with 9 other manufacturers making up the rest. That places this record below the midpoint for interventional pain medicine clinicians in OK, where the typical reported total is $5,016.
Across 104 payments — averaging $33.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Collegium Pharmaceutical, Inc.$327
- Boston Scientific$293
- GRT US Holding, Inc.$245
- Curonix LLC$98
- Forte Bio-pharma LLC$97
- plus $268 from 4 others
What the payments were for
- Food & beverage$3,45199%
- Education$291%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 53 | $2,152 |
| Collegium Pharmaceutical, Inc. | 22 | $327 |
| Boston Scientific | 2 | $293 |
| GRT US Holding, Inc. | 7 | $245 |
| Curonix LLC | 1 | $98 |
| Forte Bio-pharma LLC | 4 | $97 |
| Biodelivery Sciences International, Inc. | 6 | $87 |
| Stimwave Technologies Incorporated | 1 | $68 |
| Pfizer | 5 | $62 |
| Scilex Pharmaceuticals Inc. | 3 | $50 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$434
- INCEPTIV$259
- Qutenza$156
- Accurian$147
- Intracept$146
How this compares
$3,480 in reported general payments places this provider in the 35th percentile of 27 interventional pain medicine providers in Oklahoma.
See all interventional pain medicine providers in Oklahoma →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 814 | $83,517 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,751 | $53,677 |
| Buprenorphine | 61 | $18,849 |
| Morphine Sulfate ErMorphine Sulfate | 349 | $10,468 |
| Fentanyl | 122 | $8,705 |
| Xtampza ErOxycodone Myristate | 14 | $5,095 |
| Pregabalin | 73 | $1,833 |
| Oxycodone Hcl | 104 | $1,789 |
| Lidocaine | 14 | $1,453 |
| Pentazocine-Naloxone HclPentazocine Hcl/Naloxone Hcl | 12 | $1,018 |
| Morphine Sulfate | 48 | $519 |
| Tramadol Hcl | 57 | $491 |
| Gabapentin | 41 | $458 |
| Cyclobenzaprine Hcl | 22 | $219 |
| Methocarbamol | 12 | $193 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $327 | $5,09514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 27 interventional pain medicine providers in Oklahoma.
Other interventional pain medicine in Oklahoma City
- Brandon ValantineOklahoma City$9K
- Justin PorterOklahoma City$8K
- Blake ChristensenOklahoma City$6K
- Shawn EllisOklahoma City$6K
- Nathan OverbeyOklahoma City$5K
- Ahmed AmayemOklahoma City$5K
- Peyton JohnsonOklahoma City$5K
- Patrick PrevoOklahoma City$4K
- Arthur BeachamOklahoma City$4K
- Sanaa KarimOklahoma City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.